Inflammatory myofibroblastic tumours of the respiratory tract: A series of three cases with varying clinical presentations and treatment

Author:

Tegeltija Dragana1,Lovrenski Aleksandra1,Stojanovic Goran2,Bijelovic Milorad3,Jelicic Ivana4,Eri Zivka1

Affiliation:

1. Center for Pathology, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica + Faculty of Medicine, Novi Sad

2. Center for Bronchologic Diagnostics, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica

3. Faculty of Medicine, Novi Sad + Institute for Pulmonary Diseases of Vojvodina, Department for Thoracic Trauma, Sremska Kamenica

4. General Hospital, Department for Pathology, Vrbas

Abstract

Introduction. Inflammatory myofibroblastic tumor in the respiratory system is a rare and controversial disease. It is macroscopically well-circumscribed, non-encapsulated, firm and usually a yellowish-white mass. Histologically it is composed of the following spindled and inflammatory cells: lymphocytes, plasma cells, and histiocytes, including Touton type multinucleated giant cells. Case Outline. The series included a 49-year-old man with a tracheal inflammatory myofibroblastic tumor who complained of hoarseness; a 42-year-old man who was coughing and had a blood-stained sputum, and inflammatory myofibroblastic tumor was in the right main and intermediate bronchus; and a 32-yearold man with chest pain and inflammatory myofibroblastic tumor as a solitary peripheral nodule in the left lower lobe. In all the cases, the tumor was resected bronchoscopically and surgically. Conclusion. Inflammatory myofibroblastic tumor of the lung and the trachea is rare. Complete resection, when possible, should be the choice of treatment. After the complete removal, prognosis is generally excellent and recurrences are rare.

Publisher

National Library of Serbia

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3